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ABSTRACT 
The  time-course  of  intranuclear  Simian  virus  40  (SV40)  tumor  (T)  antigen 
synthesis  and  accumulation  in  permissive  CV1  monkey cells  and  nonpermissive 
3T3  mouse ceils has  been  studied  by immunofluorescence  and  cytofluorometry. 
CV1 cells accumulate T antigen continuously over a period of 48 h after infection, 
whereas  in  3T3  cells  the  T-antigen  content  remains  about  constant  and  at  a 
comparatively  low level.  Only those  CV1  cells  which have  attained  a  threshold 
concentration  of  intranuclear  T  antigen  synthesize  viral  capsid  proteins  (V 
antigen).  In nonpermissive  3T3 cells, the T-antigen threshold value for the onset 
of V-antigen synthesis is higher than in CV1 cells and is never reached by infected 
cells.  However,  3T3  cells  microinjected  with  sufficient  amounts  of SV40  DNA 
easily surpass this value and behave permissively. 
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In Simian virus 40 (SV40)-infected cells, intranu- 
clear  SV40  tumor  (T)  antigen  is  demonstrable 
under  permissive  and  nonpermissive  conditions 
(21).  T  antigen  is  a  virus-coded  protein  with  a 
molecular weight of ~90  kdaltons  (4,  5,  9,  12, 
16, 19). Multiple functions are attributable to this 
protein  (22, 23). T antigen stimulates DNA syn- 
thesis of resting cells, as shown by microinjection 
of  early  virus-specific  RNA  (9)  or  purified  T 
antigen  (R.  Tjian  et  al.,  manuscript  in  prepara- 
tion).  It  is  also  necessary  for initiation  of viral 
DNA  replication,  thereby  mediating  late  viral 
gene expression  (V-antigen synthesis) (7,  18). In 
this  study,  we  investigate  the  intranuclear  accu- 
mulation  of T  antigen  by fluorescence  measure- 
ment of antibody-stained permissive and nonper- 
missive  cells at different times after infection and 
a possible  quantitative  correlation  between  early 
and late viral gene expression￿9 
MATERIALS  AND  METHODS 
Cells 
Cv1 cells, an African green monkey kidney cell line 
(13), Baib/c 3T3 cells, and SV80 cells, a human trans- 
formed cell line (20,  kindly provided by M.  Osborn), 
were  grown  in  Dulbecco's  modified Eagle  medium 
(Grand  Island  Biological Co.,  Grand  Island,  N.  Y.) 
containing 10%  newborn calf serum (Gibco Bio-Cult, 
Glasgow, Scotland. 
Virus and Viral DNA 
Wild type (wt) SV40 strain 777 and the mutant strain 
tsA7 virus were plaque-purified three times before use. 
SV40 empty capsids were prepared from virus stocks by 
CsCI equilibrium  density  gradient  centrifugation  (3). 
The empty particle band  (buoyant density  1.29-1.30) 
was recycled through CsCl equilibrium density gradients 
twice. SV40 DNA was isolated from the virus by sodium 
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fied by CsCl-ethidium bromide equilibrium density gra- 
dient centrifugation (10), yielding the supercoiled circu- 
lar DNA form I and the nicked circular DNA form II. 
For  microinjection, SV40  DNA  I  was  dissolved  at  a 
concentration of 1 mg/ml in 0.01  M Tris-HCl, pH 7.4. 
Microinjection Procedure 
Cells grown on glass slides were  microinjected with 
10  TM  to 2  x  10  n  ml of injection solution per cell with 
our glass capillary microinjection technique (7, 9). 
Detection of Viral Antigens 
sv40 T and V antigens were determined by the direct 
immunofluorescence technique with fluoresceine-conju- 
gated hamster anti-T IgG (kindly provided by G. Fey) 
and  rhodamine-B  conjugated  guinea  pig  anti-V  IgG 
(Berlin), respectively. Cells on glass slides were fixed in 
acetone-methanol (2:1) at -20~  for 10 rain, air-dried, 
covered  with  the  appropriate  antibody  or  a  double 
concentrated mixture of both antibodies (total volume 
10  p,l),  incubated in a  humid chamber at 37~  for 45 
rain,  and  extensively  washed  with  phosphate  buffer. 
Fluorescence was observed with a  Zeiss universal fluo- 
rescence  microscope  equipped  with  a  mercury  HBO 
100W/2  lamp,  a  fluorescence  condensor  III  RS  and 
Zeiss filter sets code  nos.  48 77  10 and 48 77  15  for 
fluoresceine and rhodamine, respectively. 
Cyto  fluorometry 
For  cytofluorometric  quantitation  of  intranuclear T 
antigen, confluent cultures of CV1 or 3T3 cells,  grown 
on glass slides, were infected. After an adsorption time 
of 2 h, cells were washed and further incubated in serum- 
free medium until fixation and staining. 
The T-antigen concentration was  measured  in  arbi- 
trary  units (AU) with a  Zeiss fluorescence photometer 
01  equipped  with  an  operation  and  control  unit,  an 
electrically operated shutter,  a  light modulator,  and  a 
digital  printer XP2.  Each  single cell nucleus was first 
adjusted by phase contrast and transmitted light, then 
measured with 7 ms excitation time and reflected light, 
the  surroundings being masked  by  insertion of  a  dia- 
phragm.  Fig,  1  demonstrates that  the  intranuclear T- 
antigen fluorescence of a single SV80 cell remains nearly 
constant when measured frequently with short excitation 
times,  but  falls  off when  continuously excited.  In  all 
quantitatior  experiments,  identically  stained  semicon- 
fluent SV80 ceils served as a biological standard whose 
intranuclear  T-antigen  fluorescence  was  13-27  AU 
(mean value 22 AU) under the conditions used, irrespec- 
tive of whether cells were stained for T  and V  antigen 
simultaneously or for T  antigen alone. With the direct 
immunofluorescence technique, the measured AU cor- 
relates linearly with the amount of the antigen (17). 
RESULTS 
Time-Course of Intranuclear T- and 
V-Antigen Accumulation in CVI Cells 
In CV1  cells, infected with  100 plaque-forming 
units (PFU) of SV40 777 per cell, intranuclear T 
antigen  is  first  demonstable  12  h  post  infection. 
At  this  early  time,  4-5%  of  the  infected  cells 
exhibit  intranuclear  T-antigen  fluorescence  as 
tested  by  the  direct  immunofluorescence  tech- 
nique.  24-h  after infection,  99%  of the  cells are 
T-antigen-positive.  At  lower  multiplicities  of  in- 
fection (MOI) (MOI:10 or 1 PFU/cell), the onset 
of  T-antigen  accumulation  is  delayed  and  the 
number of T-antigen-positive cells  is lower  (Fig. 
2). 
However,  independent  of  the  MOI,  both  the 
number of T-antigen-positive cells and the inten- 
sity of the intranuclear T-antigen-specific fluores- 
cence increase as the incubation time is prolonged. 
To  quantitate  this  increase,  we  measured  the 
intranuclear  T-antigen  fluorescence  in  SV40-in- 
fected  CV1  cells  in  AU,  using  a  microscope 
fluorescence  photometer.  Fig.  3  illustrates  the 
changes during the first 48 h in the intranuclear T- 
antigen  concentration  in  CV1  cells  infected  with 
100  PFU  per cell.  12  h  after infection, when  4- 
5%  of  the  cells  are  T-antigen-positive  (Fig.  2), 
70% of these cells have a T-antigen concentration 
of 3-10 AU. However, a  considerable number of 
T-antigen-positive cells already have antigen con- 
centrations up to 20 AU (indicated by the bars in 
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FIGURE  1  Decrease  of  SV80  intranuclear  T-antigen 
fluorescence  with  prolonged  excitation  time.  Single 
SV80 cells were excited over a 5-min period either every 
10 s for 7 ms (0) or continuously (O). 
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FIGURE  2  Time-course of SV40 T-antigen synthesis  in 
CV1 cells infected with 100 (Q), 10 (A), or 1 (11) PFU 
per cell. 
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FIGURE  3  Time-course of SV40  T-antigen  concentra- 
tion in  CV1  cells infected with  100  PFU per cell. For 
each  time  point,  >100  randomly  chosen  cells  were 
measured.  Columns  represent  the  T-antigen  fluores- 
cence of 70% of the cells; minimal and maximal values 
are given by  the bars.  The T-antigen content of SV80 
reference cells is inserted. The dotted line represents the 
threshold value of T  antigen below which  V antigen is 
not  detectable.  Values  given  are  reproducible  within 
+-10%. 
Fig.  3).  24  h  post  infection, when  -99%  of the 
cells are T-antigen-positive,  70%  have a  fluores- 
cence intensity of 26-46  AU. After this time, the 
number  of  T-antigen-positive  cells  does  not 
change,  but  T-antigen  concentration  per  cell  in- 
creases  continuously  for  48  h  after  infection. 
Observation was stopped at this point, since onset 
of cell lysis alters the initial measuring conditions. 
With lower input multiplicities (10,  1.0, 0.1 PFU/ 
cell),  intranuclear  T-antigen  accumulation  pro- 
ceeds more slowly, as shown  in Fig. 4  for a  MOI 
of 1 PFU per cell. 
SV40  capsid  protein  (V  antigen)  synthesis  is 
only  demonstrable  after  the  onset  of viral  DNA 
replication  (2,  21).  To  measure  the  number  of 
capsid molecules necessary to obtain a  detectable 
intranuclear  V-antigen  antibody  reaction,  empty 
SV40  capsids  were suspended  in  injection buffer 
at different concentrations and  microinjected into 
the  nuclei of CV1  cells.  Immediately after injec- 
tion, cells were fixed and stained with rhodamine- 
B-conjugated anti-V serum. The minimal concen- 
tration  of capsid protein required for a  detectable 
immunofluorescence  reaction  is 4  mg/ml.  Under 
these conditions,  -500-1,000  empty SV40 parti- 
cles  are  microinjected  into  a  recipient  cell.  In 
SV40-infected  CV1  cells, this  intranuclear  V-an- 
tigen  concentration  is  obtained  -6  h  after  T- 
antigen appearance  (Figs. 2 and 5). 
Quantitative Correlation between 
Intranuclear  T-Antigen Accumulation and 
V-Antigen  Synthesis 
When  SV40-infected  cells were  stained  with  a 
mixture  of fluoresceine-conjugated  anti-T  serum 
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FIGURE 4  Time-course of SV40 T-antigen  concentra- 
tion in CV1 cells infected with 1 PFU per cell. Details as 
described in the legend to Fig. 3. 
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FIGURE 5  Time-course of SV40 V-antigen synthesis in 
CV1 cells infected with 100 (0), 10 (&), or 1 (i) PFU 
per cell. 
and rhodamine-conjugated anti-V serum, a quan- 
titative correlation between intranuclear T-antigen 
concentration  and  V-antigen  synthesis  was  im- 
plied. Independent  of the  MOI,  V-antigen-posi- 
tive cells always showed a  strong intranuclear T- 
antigen-specific  fluorescence  (Fig.  6).  To  test 
whether a  measurable correlation exists between 
the relative amount of intranuclear T-antigen and 
V-antigen synthesis, the T-antigen concentration 
of V-antigen-positive CV1  cells was measured in 
AU at different times after infection. Independent 
of  the  MOI  (100,  10,  1,  0.1  PFU/CelI),  the 
minimal concentration of T  antigen in V-antigen- 
positive cells is 28 AU (dotted line in Figs. 3 and 
4), but the higher the MOI, the sooner this value 
is attained. However, not all CV1 cells having this 
amount  of T  antigen  are  necessarily V-antigen- 
positive. The  distribution of intranuclear T-anti- 
gen concentration and its correlation with V-anti- 
gen synthesis is illustrated in Fig. 7 for a popula- 
tion of 300 CV1  cells 32 h after infection with 10 
PFU per cell. 
To test whether the continuous intranuclear T- 
antigen  accumulation  is  due  to  the  increase  of 
viral DNA template molecules, we measured the 
T-antigen content  of infected CV1  cells blocked 
for  DNA  synthesis  by  5-fluorodeoxyuridine 
(FUdR;  15  /.Lg/ml medium;  0-48  h  post  infec- 
tion). Control experiments with autoradiography 
revealed  no  incorporation  of  [aH]thymidine  at 
these  conditions (data not  shown).  As expected 
(14), V antigen is not detectable at any time, but 
T-antigen accumulation is unaffected by the pres- 
ence  of  the  drug  (data  not  shown).  CV1  cells 
infected with the early temperature-sensitive mu- 
tant  virus tsA7 and continuously held at 41.5~ 
also surpass the T-antigen threshold concentration 
of  28  AU  without  synthesizing  V  antigen  in 
detectable amounts. 
Time-Course of T- and V-Antigen 
Synthesis in 3 T3 Cells 
Mouse cells (3T3) infected with SV40 virus by 
the  conventional  virus  adsorption  method  are 
nonpermissive for  SV40  (21).  Fig.  8  shows  the 
time-course of T-antigen  formation  in  3T3  cells 
infected with  500  and  50  PFU/ceI1.  With  these 
MOI's, T-antigen formation is first demonstrable 
17  and  24  h,  respectively, after infection.  Only 
with the high MOI and an  incubation time of at 
least 65  h  do nearly  100%  of the  infected cells 
become T-antigen-positive, but V antigen was not 
demonstrable at any time after infection. Further- 
more, the mean value of the intranuclear T-anti- 
gen concentration does not exceed that of SV80 
cells  (Fig.  9).  As  reported  recently,  3T3  cells 
support  early  and  late  SV40  gene  expression 
either  after  microinjection  of  at  least  200-400 
SV40 DNA I molecules or after microinjection of 
early  virus-specific  RNA  together  with  20-40 
DNA I  molecules per clel (6). Fig.  10 shows the 
time-course of T- and V-antigen formation after 
microinjection of 2,000-4,000  SV40 DNA I mol- 
ecules into  the  nuclei of 3T3  cells. 70%  of the 
injected cells had  a  T-antigen  concentration  be- 
tween  40  and  59  AU  48  h  after  microinjection 
(Fig. 9).  The  fluorescence intensity of 3T3  cells 
microinjected with a known number of purified T- 
antigen  molecules is  comparable  to  the  fluores- 
cence  intensity  of  microinjected  CV1  cells  (A. 
Graessmann et al., manuscript in preparation). In 
this nonpermissive cell type, the minimal concen- 
tration  of  T  antigen  in  V-antigen-positive cells 
turns  out  to  be  52  AU  (dotted line  in  Fig.  9). 
With 100-200  SV40 DNA molecules transferred 
per recipient cell, the intranuclear T-antigen con- 
centration  is  always lower than  40  AU.  No  V- 
antigen synthesis can be detected in these ceils at 
any time tested. 
DISCUSSION 
The subdivision of the SV40  infection cycle into 
an early and a late phase is not merely a phenom- 
enologieal  description,  since  late  SV40  gene 
expression depends on  sufficient synthesis of the 
early virus-coded protein  (T antigen, A  protein) 
114  RAPID  COMMUNICATIONS FIGURE 6  CV1  cells  stained  with  a  mixture  of  fluoresceine-conjugated  anti-T  and  rhodamine-B- 
conjugated anti-V antibodies 28 h after infection with 10 PFU per cell. (a) SV40 T-antigen and (b) SV40 
V-antigen fluorescence. Bars, 10/~m. 
in terms of both quantity and quality. This inves- 
tigation has yielded strong evidence that late viral 
gene  expression  (V-antigen  synthesis)  depends 
upon a  threshold concentration of intranuclear T 
antigen.  The  double-staining  experiments  show 
that a  T-antigen content equivalent to 28  AU is 
the  minimal  concentration  attained  before  the 
onset  of V-antigen  synthesis in  monkey  kidney 
(CV1)  cells. Preliminary results obtained by mi- 
croinjection of the purified T antigen indicate that 
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FIGURE  7  Distribution of intranuclear SV40 T-antigen 
concentration and correlation of T-antigen content to V- 
antigen appearance in CV1 cells 32 h after infection with 
10 PFU per cell. 300 double-stained cells were measured 
for T-antigen fluorescence  and checked  for  V  antigen 
simultaneously. Hatched areas represent percent of total 
cells which are T- and V-antigen-positive. 
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FIGURE  8  Time-course of SV40 T-antigen synthesis in 
3T3 cells infected with 500 (0) or 50 (11) PFU per cell. 
this  value  corresponds  to  about  10  6  T-antigen 
molecules  (A.  Graessman  et  al.,  manuscript  in 
preparation). 
Since  intranuclear  T-antigen  formation  is  not 
affected  in  cells blocked  for  DNA  synthesis, the 
accumulation  of these high amounts of T  antigen 
is not a consequence of an increase in the number 
of viral template  molecules, but  is rather needed 
for the onset of viral DNA replication as a prereq- 
uisite for late viral gane expression (2, 7). 
It  is  still  unknown  how  T  antigen  stimulates 
cellular and viral DNA synthesis. However, induc- 
tion  of cellular  DNA  synthesis can  be  separated 
from  viral DNA  replication experimentally,  e.g.: 
(a)  at  the  nonpermissive  temperature,  early  ts 
mutants  stimulate  cellular  but  not  viral  DNA 
synthesis  (1)  although these  cells surpass  the  28 
AU  T  antigen  concentration;  (b)  stimulation  of 
cellular  DNA  synthesis  requires  a  significantly 
lower  T-antigen  concentration  than  viral  DNA 
synthesis as shown by microinjection of purified T 
antigen  (A.  Graessmann  et  ai.,  manuscript  in 
preparation); (c) induction of cellular but not viral 
DNA synthesis can be obtained by microinjection 
of an  SV40  DNA  fragment  lacking  20%  of  the 
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FIGURE  9  Time-course of SV40 T-antigen concentra- 
tion  in  3T3  cells  infected  with  500  PFU  per  cell. 
Intranuclear T-antigen fluorescence of 3T3 cells microin- 
jected  with  2,000-4,000  SV40  DNA  I  molecules  is 
additionally given (-.-).  Details as described in the 
legend to Fig.  3. 
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FIGURE 10  Time-course of T- and V-antigen synthesis 
in  3T3  cells  microinjected with  SV40  DNA  I.  DNA 
concentration  was  1  mg/ml,  corresponding  to  2,000- 
4,000  DNA  I  molecules transferred per recipient cell. 
Each  time  point is based  on  a  count of  200  cells.  T 
antigen (A), V antigen (A). 
R6  RAPID  COMMUNICATIONS early region (11;  C.  Mueller et al.,  manuscript in 
preparation).  From  these  observations,  at  least 
two  alternatives can  be  deduced  for  the  possible 
mode  of T-antigen  action:  (a)  cellular  and  viral 
DNA  synthesis  are  stimulated  in  distinct  ways, 
maybe even by different sites; and (b) a  common 
function induces cellular and viral DNA synthesis, 
although with different specificities. 
Late SV40 gene expression in the "nonpermis- 
sive"  mouse  cell  needs  a  T-antigen  threshold 
concentration  of  -52AU.  This  amount  is  easily 
obtained  by  microinjection  of  large  numbers  of 
SV40  DNA  molecules,  but  not  by  conventional 
virus infection (Fig.  9).  In  contrast to permissive 
ceils  (Fig.  2),  3T3  ceils  do  not  accumulate  T 
antigen  continuously,  even  when  infected  with 
500  PFU  per cell.  These  cells  may  synthesize T 
antigen  less  efficiently  and/or  degrade  it  at  a 
higher rate than monkey  cells.  Since the intranu- 
clear presence  of at least  250-500  viral particles 
or  viral  DNA  molecules  overcomes  nonpermis- 
siveness (6, 8), a very early event in the infectious 
cycle  (adsorption,  penetration,  intracellular 
release) must be additionally involved in the non- 
permissive  type  of  response  in  infected  mouse 
cells. 
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